Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
943 of 1,108 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,448 total, page 19 of 29
Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial
NCT02223520
The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism
NCT02200263
A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients
NCT02253264
Miradry Treatment for Focal Axillary Hyperhidrosis
NCT02295891
Environmental Control as Add-on Therapy in Childhood Asthma
NCT02251379
NVAMD Satellite Study
NCT02251366
Functional Assessment of Coronary Artery Disease by CTA Flow Encoding
NCT02286401
Pharmacokinetics and Pharmacodynamics of the Etonogestrel Contraceptive Implant When Co-administered With Efavirenz
NCT01980342
tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis
NCT02538094
Remote Ischemic Preconditioning to Prevent Contrast Nephropathy
NCT02674451
MIND: Care Coordination for Community-living Person With Dementia
NCT02396082
Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
NCT02116309
Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence
NCT02111798
EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors
NCT02282111
Pre-op Paravertebral Blocks to Decrease Post-op Pain Following Mastectomy With Immediate Tissue Expander (TE) Reconstruction
NCT02161705
Pharmacogenomics of Antiplatelet Response
NCT02234427
Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis
NCT02165176
Stylet vs No Stylet During EBUS TBNA
NCT02201654
Bariatric Embolization of Arteries for the Treatment of Obesity
NCT02165124
An Intervention to Reduce Delirium After Cardiac Surgery
NCT02587039
Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers
NCT03638687
Topical Itraconazole in the Treatment of Basal Cell Carcinoma
NCT02120677
Fluoroscopically-guided Versus Landmark-guided Sacroiliac Joint Injections
NCT02096653
Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma
NCT02160925
Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
NCT02145091
Comparison of Femtosecond Laser Assisted Cataract Surgery to Conventional Phacoemulsification Cataract Surgery
NCT02096627
MRI Outcomes of Mindfulness Meditation for Migraine
NCT02133209
Educating Nurses About Venous Thromboembolism (VTE) Prevention
NCT02301793
Prevention of Alcohol Intolerance
NCT01845220
Effects of Hallucinogens and Other Drugs on Mood and Performance
NCT02033707
Using Peer Mentors to Deliver Depression Care
NCT02261818
Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study
NCT02116322
Safety Study of Post Intravenous tPA Monitoring in Ischemic Stroke
NCT02039375
Early Detection of Pancreatic Cystic Neoplasms
NCT02110498
Medial Branch Blocks vs. Intra-articular Injections: Randomized, Controlled Study
NCT02002429
Clinical Trial of Air Cleaners to Improve Indoor Air Quality and COPD Health
NCT02236858
Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome
NCT01817517
The Baltimore HEARS Pilot Study
NCT02045511
Effects of Reducing Indoor Air Pollution on the Adult Asthmatic Response
NCT02153359
Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)
NCT02166346
Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests
NCT02252198
The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis
NCT02078375
Evaluating Peanut Immunotherapy Dissolving Film in Healthy Subjects
NCT03070561
Study of the Effectiveness of Ozurdex for the Control of Uveitis
NCT02049476
Stop Community MRSA Colonization Among Patients
NCT02029872
mActive: A Blinded, Randomized mHealth Activity Trial
NCT01917812
Randomized Evaluation of Ten Allergy Skin Prick Test Devices
NCT03509766
Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines
NCT02031679
The Role of Cerebral Oximetry in Pediatric Concussion Assessment
NCT02036333
Short Forearm Casting Versus Below-elbow Splinting for Acute Immobilization of Distal Radius Fractures
NCT02679066
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johns Hopkins University: open-pipeline peers nationwide
Peers matched on 1,448 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Johns Hopkins University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,448 trials (± recruiting share)
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Yale University · 1,492 trials · 17% recruiting
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Seattle Children's Hospital · 17% recruiting · 168 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
- Virginia Polytechnic Institute and State University · 17% recruiting · 104 trials
Related
What to do with this Johns Hopkins University page
1,448 registered trials is a research-attention snapshot, not an endorsement of Johns Hopkins University or any single study.
- 250 of Johns Hopkins University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Johns Hopkins University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Johns Hopkins University pipeline card: 1,448 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.